FORM4API
ExploreSearch any ticker for its insider tradesFilingsThe newest Form 4 filings, market-wideForm 144Intent to sell, filed before the trade13F FilersInstitutional 13F-HR filers by AUMSignalsCluster buy & sell signalsScreenerFilter trades by code, size & returnCongressSTOCK Act trades disclosed by Congress
PricingDocs
SEC Form 4 explainedSEC Form 144 explained13F-HR filings explainedCluster buy signals10b5-1 trading plans
All guides →
Sign inGet a keyDashboard

Insider profile

Lindsay A Rosenwald MD Insider Trading

This page tracks every SEC Form 4 filing since April 2023 by Lindsay A Rosenwald MD, President, CEO & Chairman: 37 transactions in total, including 19 open-market purchases and 0 sales. Each record is parsed directly from the original filing, with amendments reconciled so a corrected filing never double-counts.

Role
President, CEO & Chairman · Director
CIK
0000941841
Companies traded
4
Total filings
37
First filing
2022-03-18
Last filing
2026-06-25

Files as ROSENWALD LINDSAY A MD · SEC EDGAR ↗

Activity summary

The most recent open-market decision, on September 23, 2024, was 2 purchases totaling 1,526,718 shares ($1.5M).

Three year balance

Buy and sell value by quarter, Q3 23 to Q2 26. Lindsay A Rosenwald MD has been a net buyer across the period shown.

PurchasesSales
Q3 23$2.7MQ4 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $2.7M.

Insider insight

Lindsay A Rosenwald MD trades most actively in FBIO, accounting for 11 of the 37 filings on record. The largest single open-market purchase on record is $2.7M in FBIO, filed Nov 2023.

Track record

$5.3M
Total purchased
$0
Total sold
17
17 buys · 0 sales
Net buyer
Overall direction

Most active in

FBIO11 buysDERM3 buysMBIO2 buysATXI1 buy
Largest trade: $2.7M in FBIO (Nov 2023) in last 37Filing history: Mar 2022 – Jun 2026Under a 10b5-1 plan: 0%Full history: 37 filings

Transaction History

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValueReturn
Jun 25, 2026Lindsay A Rosenwald MDDERM
Award
10,000——-4.7% 1m
Mar 18, 2026Lindsay A Rosenwald MDFBIO
Award
475,424——-17.1% 6m
Aug 5, 2025Lindsay A Rosenwald MDDERM
Award
50,000——+14.4% 6m
Jun 25, 2025Lindsay A Rosenwald MDDERM
Award
7,173——+0.1% 6m
May 30, 2025Lindsay A Rosenwald MDCKPT
U
207,007——Pending

32 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/insiders/0000941841/transactions" \
  -H "X-Api-Key: $KEY"
Get a key

Companies traded

By number of filings.

FBIO11 filings
DERM3 filings
MBIO2 filings
ATXI1 filing

Filing cadence

Filings per quarter, this window.

2.1filings / quarter, Q1 22–Q2 26

Busiest: Q3 24 (7 filings)

Quietest: Q2 22 (0 filings)

Reading an insider's Form 4 history

Corporate insiders (directors, officers, and holders of more than 10% of a company's stock) must report their trades to the SEC on Form 4 within two business days. Looking at one insider's filings over time shows whether they tend to buy on the open market (a discretionary use of their own money, generally the strongest signal), sell, or simply receive and exercise equity awards as compensation.

The track record above measures how this insider's past open-market purchases performed in the months after each filing. Trades made under a pre-scheduled Rule 10b5-1 plan are flagged because they carry no timing signal. To pull any insider's full history programmatically, see the insider trading API or our guide to reading Form 4 filings.

FORM4API

Real-time SEC Form 4, Form 144, 13F-HR and congressional trading data, over a REST API and webhooks.

Data
  • Screener
  • Filings
  • Signals
  • Companies
  • Insiders
  • Congress trades
  • 13F filers
  • Explorer
  • Top insiders
Developers
  • Documentation
  • Insider trading API
  • Python SDK
  • TypeScript SDK
  • MCP server
  • Status
Company
  • Pricing
  • Guides
  • Compare
  • About
  • Data quality
  • Privacy
  • Terms
Form4API, StockholmNot affiliated with the SEC or EDGAR. Data sourced from public EDGAR filings. Not investment advice.

Scorecard

29%
Buys positive after 3m
-5.8%
Avg return at 3m
-14.2%
Median return at 3m
17
Scored buys
Best buy: DERM+126.4% 3m (Sep 2023)Worst buy: ATXI-82.9% 3m (Sep 2023)

Absolute post-filing return, not market-adjusted · min. 5 matured open-market buys

See top insiders by track record →

Related insiders

Other insiders filing on FBIO.

David JinChief Financial OfficerDov KleinDirectorMichael S WeissCEO and President